BioMed Realty Trust, Inc. (NYSE: BMR) is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry.
As of December 31, 2007, BioMed owned or had interests in 67 properties, representing 103 buildings with approximately 8.5 million rentable square feet of laboratory and office space, as well as approximately 1.9 million square feet of development in progress.
The Company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research.
BioMed's focused execution on its unique business model led to another tremendous year in 2007, including 1.5 million square feet of leasing transactions across all of its core markets. Another major highlight for the year was the Company's entry into a $507 million joint venture with Prudential Real Estate Investors, the first such partnership of size and scale in the life science real estate market.
The Company's success in 2007 represents a clear validation of the Company's business model, premier management team, and proven ability to execute on opportunities and create value for shareholders.
Additional information is available at www.biomedrealty.com.
